FDA Inspection
Lilly del Caribe, Inc.Lilly del Caribe, Inc. – FDA Inspection, Feb 17, 2023
Record Details
This FDA Inspection record concerns Lilly del Caribe, Inc., with an inspection on February 17, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c2c92c4c-c540-4128-90a5-30550b167b83
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1198613
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Lilly del Caribe, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| May 12, 2026 | Not classified | San Juan District Office | |
| September 27, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 1, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 4, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lilly del Caribe, Inc.
- FDA Inspection 1321482 - 2026-05-12
- FDA Inspection 1069980 - 2018-09-27
- FDA Inspection 974723 - 2016-06-01
- FDA Inspection 868382 - 2014-02-21
- FDA Inspection 776200 - 2012-04-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.